Skip to main content
Download PDF

Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study

BMC Cancer volume 16, Article number: 369 (2016) Cite this article

The Original Article was published on 24 February 2016

Erratum

After publication of the original article [1], the authors noticed an error in the Acknowledgements section. The Acknowledgement contains missing information. The correct version of the Acknowledgements section is included below:

References

  1. Bridgewater J, Lopes A, Beare S, Duggan M, Lee D, Ricamara M, et al. A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study. BMC Cancer. 2016;16:153. doi:10.1186/s12885-016-2174-8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The research was funded in part by AstraZeneca and carried out at, and supported by, the National Institute for Health Research (NIHR UCLH Clinical Research Facility and the Cancer Research UK Experimental Cancer Medicine Centre (ECMC). Central coordination of the study was supported by Cancer Research UK (Grant reference C1813/A12155) and AstraZeneca. Conduct of the trial at hospital sites was supported through the National Institute of Health Research Clinical Research Network and AstraZeneca. We also acknowledge the support of the AMMF (www.ammf.org.uk/) and the IBTCC (International Biliary Tract Cancer Collaboration). JB is partly funded by the UCLH/UCL NIHR Biomedical Research Centre.

Author information

Authors and Affiliations

  1. UCL Cancer Institute, 72 Huntley St, London, WC1E 6DD, UK

    John Bridgewater & Maravic Ricamara

  2. Cancer Research UK and UCL Clinical Trials Centre, London, UK

    Andre Lopes, Sandra Beare, Marian Duggan & Dymphna Lee

  3. The Christie NHS Foundation Trust, Manchester, UK

    Delyth McEntee & Juan W. Valle

  4. Imperial College Healthcare, London, UK

    Ajithkumar Sukumaran & Harpreet Wasan

Authors
  1. John Bridgewater
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andre Lopes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandra Beare
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marian Duggan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dymphna Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maravic Ricamara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Delyth McEntee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ajithkumar Sukumaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Harpreet Wasan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Juan W. Valle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Bridgewater.

Additional information

The online version of the original article can be found under doi:10.1186/s12885-016-2174-8.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bridgewater, J., Lopes, A., Beare, S. et al. Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study. BMC Cancer 16, 369 (2016). https://doi.org/10.1186/s12885-016-2403-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-016-2403-1

BMC Cancer

ISSN: 1471-2407

Contact us